Hjem › Leversygdomme › Utah
Leversygdomme kliniske forsøg i Utah
6 studier for Leversygdomme søger deltagere på steder i Utah.
Byer i Utah
Officiel studietekst (engelsk)
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Ogden
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Sandy City
- 89bio Clinical Study Site, West Jordan
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 3. sep. 2026 · NCT06419374Primary Sclerosing Cholangitis in Children
- The University of Utah, Salt Lake City
RekruttererObservationsstudie
Alder 2 til 25 · Alle køn · Opdateret 14. jul. 2026 · NCT04181138A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Intermountain Health, Salt Lake City
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. dec. 2025 · NCT06619561Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- University of Utah Health, Salt Lake City
RekruttererObservationsstudie
Alder 18 til 80 · Alle køn · Opdateret 20. okt. 2025 · NCT04613921Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)
- University of Utah, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Salt Lake City
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 25. maj 2025 · NCT06193928Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.